Zolmitriptan (311C90) selectively binds to and activates serotonin (5-HT) 1B receptors expressed in intracranial arteries and 5-HT 1D receptors located on peripheral trigeminal sensory nerve terminals in the meninges and central terminals in brainstem sensory nuclei. Zolmitriptan is a member of the triptan class of agents with anti-migraine properties. Receptor binding results in constriction of cranial vessels, reduction of vessel pulsation and inhibition of nociceptive transmission, thereby providing relief of migraine headaches. Zolmitriptan may also relieve migraine headaches by inhibition of pro-inflammatory neuropeptide release.
Molecular Weight:
287.36
Purity:
0.9991
CAS Number:
[139264-17-8]
Formula:
C16H21N3O2
Target:
5-HT Receptor|||Endogenous Metabolite
T1092
* VAT and and shipping costs not included. Errors and price changes excepted
